Back

mr. dr. G.H. (Filip) de Vuure

mr. dr. G.H. (Filip) de Vuure

Assistant Professor - medical
mr. dr. G.H. (Filip) de Vuure
  • Department of Medical Oncology

Research Programs

Strategic Program Cancer

Biography

Biography

 

Education

 

1993 –   1996

 

1996 –   2000

 

2004

 

 

 

2010

 

 

 

 

Pre-MedicalSchool at Limburg   UniversityCenter,   Hasselt, Belgium 

 

MedicalSchool at University   of Antwerp, Antwerp, Belgium (MD)

 

PhD thesis: “Balance between desired and unwanted effects   of chemotherapeutic and anti-angiogenic drugs” at department of   Medical Oncology at the University    of Groningen, The   Netherlands

 

Degree: Medical Oncologist, University   of Rotterdam, The Netherlands

 

Additional training

 

2013

 

 

 

2013

 

 

2014

 

 

12th Masterclass in Clinical   Oncology by the European School of

Oncology (ESO) and European   Society of Medical Oncology

(ESMO)

 

Clinical   Trial Statistics for Non-Statisticians by the European

Organization   for Research and Treatment in Cancer (EORTC)

 

Basic   Course Legislation and Organization for Clinical Researchers

(BROK)

 

 

Professional  experience

 

2008 – 2010

 

 

2010 – 2011

 

 

2011 –   present

 

 

 

Fellow, Dept of Medical Oncology, ErasmusMedical   Center, Rotterdam,   The Netherlands

 

Staff member, Dept of Medical Oncology, Radboud   University Nijmegen Medical Centre, Nijmegen,   The Netherlands

 

Staff member, Dept of Medical Oncology, University of Utrecht,   Utrecht, the Netherlands

 

Since start of PhD thesis   extensive experience with clinical trials

 

 

Research Output (84)

Study protocol of the GLOW study:maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics-a prospective multicenter cohort study

van Opijnen Mark P, Broekman Marike L D, de Vos Filip Y F, Cuppen Edwin, van der Hoeven Jacobus J M, van Linde Myra E, Compter Annette, Beerepoot Laurens V, van den Bent Martin J, Vos Maaike J, Fiebrich Helle-Brit, Koekkoek Johan A F, Hoeben Ann, Kho Kuan H, Driessen Chantal M L, Jeltema Hanne-Rinck, Robe Pierre A J T, Maas Sybren L N 4 Nov 2022, In: BMC Medical Genomics [E]. 15

Attitudes Toward Striving for Quality and Length of Life Among Patients With Advanced Cancer and a Poor Prognosis

van der Velden Naomi C A, van Laarhoven Hanneke W M, Nieuwkerk Pythia T, Kuijper Steven C, Sommeijer Dirkje W, Ottevanger Petronella B, Fiebrich Helle-Brit, Dohmen Serge E, Creemers Geert-Jan, de Vos Filip Y F L, Smets Ellen M A, Henselmans Inge 6 Oct 2022, In: JCO oncology practice. 18 , p. e1818-e1830

Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma

Vieito Maria, Simonelli Matteo, de Vos Filip, Moreno Victor, Geurts Marjolein, Lorenzi Elena, Macchini Marina, van den Bent Martin J, Del Conte Gianluca, de Jonge Maja, Martín-Soberón Maria Cruz, Amoroso Barbara, Sanchez-Perez Tania, Zuraek Marlene, Hanna Bishoy, Aronchik Ida, Filvaroff Ellen, Chang Henry, Mendez Cristina, Arias Parro Marina, Wei Xin, Nikolova Zariana, Sepulveda Juan Manuel 2022, In: Neuro-oncology advances. 4

Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia

Stein Eytan M, DeAngelo Daniel J, Chromik Jörg, Chatterjee Manik, Bauer Sebastian, Lin Chia-Chi, Suarez Cristina, De Vos Filip, Steeghs Neeltje, Cassier Phillippe A, Tai David, Kiladjian Jean-Jacques, Yamamoto Noboru, Mous Rogier, Esteve Jordi, Minami Hironobu, Ferretti Stéphane, Guerreiro Nelson, Meille Christophe, Radhakrishnan Rajkumar, Pereira Bernard, Mariconti Luisa, Halilovic Ensar, Fabre Claire, Carpio Cecilia 3 Dec 2021, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 28 , p. 870-881 12 p.

Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR):a multicentre, open-label, single-arm, phase 2, basket trial

Wen Patrick Y, Stein Alexander, van den Bent Martin, De Greve Jacques, Wick Antje, de Vos Filip Y F L, von Bubnoff Nikolas, van Linde Myra E, Lai Albert, Prager Gerald W, Campone Mario, Fasolo Angelica, Lopez-Martin Jose A, Kim Tae Min, Mason Warren P, Hofheinz Ralf-Dieter, Blay Jean-Yves, Cho Daniel C, Gazzah Anas, Pouessel Damien, Yachnin Jeffrey, Boran Aislyn, Burgess Paul, Ilankumaran Palanichamy, Gasal Eduard, Subbiah Vivek 24 Nov 2021, In: LANCET ONCOLOGY. 23 , p. 53-64 12 p.

Added Value of Cognition in the Prediction of Survival in Low and High Grade Glioma

van Kessel Emma, Schuit Ewoud, Huenges Wajer Irene M C, Ruis Carla, De Vos Filip Y F L, Verhoeff Joost J C, Seute Tatjana, van Zandvoort Martine J E, Robe Pierre A, Snijders Tom J 18 Nov 2021, In: Frontiers in Neurology. 12 , p. 1-11

The EGFRvIII transcriptome in glioblastoma, a meta-omics analysis

Hoogstrate Youri, Ghisai Santoesha A, de Wit Maurice, de Heer Iris, Draaisma Kaspar, van Riet Job, van de Werken Harmen J G, Bours Vincent, Buter Jan, Vanden Bempt Isabelle, Eoli Marica, Franceschi Enrico, Frenel Jean-Sebastien, Gorlia Thierry, Hanse Monique C, Hoeben Ann, Kerkhof Melissa, Kros Johan M, Leenstra Sieger, Lombardi Giuseppe, Lukacova Slávka, Robe Pierre A, Sepulveda Juan M, Taal Walter, Taphoorn Martin, Vernhout René M, Walenkamp Annemiek M E, Watts Colin, Weller Michael, de Vos Filip Y F, Jenster Guido W, van den Bent Martin, French Pim J 5 Oct 2021, In: Neuro-Oncology. 24 , p. 429-441 13 p.

Comparison of 2-Hydroxyglutarate Detection With sLASER and MEGA-sLASER at 7T

Shams Zahra, van der Kemp Wybe J M, Emir Uzay, Dankbaar Jan Willem, Snijders Tom J, de Vos Filip Y F, Klomp Dennis W J, Wijnen Jannie P, Wiegers Evita C 7 Sep 2021, In: Frontiers in Neurology. 12 , p. 1-10

CONVENTIONAL MRI CRITERIA DIFFERENTIATE TRUE TUMOUR PROGRESSION FROM TREATMENT-INDUCED EFFECTS IN IRRADIATED WHO GRADE 3 AND 4 GLIOMAS

Flies C. M., van Leuken K. H., Verhoeff J. J. C., de Vos F. Y. F., Seute T., Robe P. A., Hendrikse J., Witkamp T. D., Dankbaar J. W., Snijders T. J. Sep 2021, In: Neuro-Oncology. 23 , p. ii41-ii41

Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer

Guman Noori A M, van Geffen Roos J, Mulder Frits I, van Haaps Thijs F, Hovsepjan Vahram, Labots Mariette, Cirkel Geert A, de Vos Filip Y F L, Ten Tije Albert J, Beerepoot Laurens V, Tjan-Heijnen Vivianne C G, van Laarhoven Hanneke W M, Hamberg Paul, Vulink Annelie J E, Los Maartje, Zwinderman Aeilko H, Ferwerda Bart, Lolkema Martijn P J K, Steeghs Neeltje, Büller Harry R, Kamphuisen Pieter W, van Es Nick 19 Aug 2021, In: Journal of thrombosis and haemostasis : JTH. 19 , p. 2974-2983 10 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Contact

Afspraken

Praktisch

hetwkz.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not